Press Releases

Thermogenesis Holdings to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

RANCHO CORDOVA, Calif., September 7, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference. If you are an … Continued

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update

Conference Call to be Held on August 12, 2021 RANCHO CORDOVA, Calif., August 5, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2021 … Continued

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2021 and Provide a Corporate Strategic Update

Conference Call to be Held on May 13, 2021 RANCHO CORDOVA, Calif., May 6, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2021 … Continued

ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update

Conference Call to be Held on March 17, 2021 RANCHO CORDOVA, Calif., March 10, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2020 … Continued

ThermoGenesis Holdings Begins a Year of Celebration of its 35th Anniversary in the Cell Banking and Cell Therapy Industry

Future corporate strategy targets large-scale cellular manufacturing needs for upcoming cell and gene therapies RANCHO CORDOVA, Calif., Feb. 17, 2021 — ThermoGenesis Holdings, Inc. (“ThermoGenesis” or the “Company”) (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company will kick off a … Continued

ThermoGenesis Holdings Launches a GMP Compliant Automated Cell Washing and Reformulation System — PXP™-LAVARE — for CAR-T Manufacturing

RANCHO CORDOVA, Calif., Feb. 3, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has completed the development process, submitted a Letter to File and updated the device listing with the U.S. Food and Drug Administration (FDA) … Continued

ThermoGenesis Holdings to Participate at the H.C. Wainwright BIOCONNECT 2021 Conference

RANCHO CORDOVA, Calif., Jan. 7, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Jeff Cauble, Chief Financial Officer, will present a company overview at the H.C. Wainwright BIOCONNECT 2021 Conference. The presentation will be available beginning January … Continued

How may we help?